Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings

About this resource:

Non-Systematic Review

Source: Substance Abuse and Mental Health Services Administration

Last Reviewed: 2021

Workgroups: Substance Use Workgroup

This Substance Abuse and Mental Health Services Administration (SAMHSA) resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers, strategies to overcome them, and documents step-by-step tactics to support buprenorphine implementation.

Read more about this resource

Objectives related to this resource (1)

Increase the rate of people with an opioid use disorder getting medications for addiction treatment — SU‑D03
Developmental

Suggested Citation

1.

Substance Abuse and Mental Health Services Administration. (2021). Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings. Retrieved from https://www.samhsa.gov/resource/ebp/practical-tools-prescribing-buprenorphine-primary-care.